Structure of the Herpes Simplex Virus Receptor
Encephalitis, Herpes Simplex, Keratitis
About this trial
This is an observational trial for Encephalitis focused on measuring HVEM Gene, HSV, Herpes Simplex Virus
Eligibility Criteria
INCLUSION CRITERIA: HSV-2 Seronegative Patients: Individuals known or likely to be seronegative for HSV-2 will be recruited. All racial, gender, and ethnic groups will be considered. Adult volunteers at least 18 years of age. Volunteers who were seronegative for HSV-2 (regardless of HSV-1 serology) confirmed by Western blot. Volunteers are willing to allow investigators to store their blood. HSV-2 seropositive patients (with or without symptoms): All racial and ethnic groups will be considered. Volunteers who were seropositive for HSV-2 (regardless of HSV-1 serology) confirmed by Western blot. Volunteers are willing to allow investigators to store their blood. Normal Controls: To determine the frequency of a genetic polymorphism in a population that has not had prior screening for HSV, blood may be obtained from normal control blood donors.
Sites / Locations
- National Institutes of Health Clinical Center, 9000 Rockville Pike